Company: CORT
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001628280-25-022173
Chunk: 38

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 8
Chunk 38
---
.Equity Awards OutstandingAs of March 31, 2025, we had 26.1 million stock options, 1.6 million RSAs and less than 0.1 million restricted stock units (“RSUs”) outstanding. As of December 31, 2024, we had 24.7 million stock options, 1.2 million RSAs and less than 0.1 million RSUs outstanding.Stock-based CompensationThe following table summarizes our stock-based compensation by financial statement classification:Three Months Ended March 31, 20252024 (in thousands)Capitalized stock-based compensation$144 $45 Cost of sales36 11 Research and development6,321 3,921 Selling, general and administrative15,473 9,317 Total stock-based compensation$21,974 $13,294 

7. Net Income Per Share

We compute our basic and diluted net income per share in conformity with the two-class method required for companies with participating shares. Under the two-class method, net income is determined by allocating net income between common stock and unvested RSAs. We compute basic net income per share by dividing our net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. We compute diluted net income per share by dividing our net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, including potentially dilutive stock options and unvested RSUs, less unvested RSAs. We use the treasury stock method to determine the number of dilutive shares of common stock resulting from stock options and unvested RSUs.

13

The following table shows the computation of net income per share for each period:Three Months Ended March 31, 20252024 (in thousands)Numerator:  Net income attributable to common stockholders$20,288 $27,514 Denominator:Weighted-average shares used to compute basic net income per common share104,106 102,791 Dilutive effect of employee stock options and unvested RSUs15,713 7,124 Weighted-average shares used to compute diluted net income per common share119,819 109,915 Net income per share attributable to common stockholdersBasic$0.19 $0.27 Diluted$0.17 $0.25 We excluded from the computation of diluted net income per share, on a weighted-average basis,